Thursday Sep 24
HEALTHAnthropic

Claude Finds A CRISPR-Like Enzyme System

24SEP
200,000 ENZYMESCLAUDEREPEAT ARRAY

Anthropic opened a wet lab and pointed 950 Claude agents at bacterial genomes. They surfaced an unknown enzyme family with a regular repeat pattern. Feng Zhang called it worth chasing.

Twenty-one hours. Two hundred thousand reverse transcriptases screened. Three thousand five hundred candidates cut to twenty. One of the agents wrote in its own log that the DNA looked CRISPR-like, then flagged it for humans.

The system is named ART, for array-associated reverse transcriptase. It lives in bacteriophages. A copying protein sits next to a partner gene and an evenly spaced row of short DNA motifs. Nobody knows what it does yet.

This is the first output of Anthropic's new life sciences group and its Bay Area facility. Humans still run the benches. The preprint is out. The function question is open.

full brief & sources

⚡ Why this matters

  • CRISPR started as a strange repeat pattern in bacterial DNA. That pattern became a gene editing industry. A machine just found another one.
  • The search was not a chatbot answering a question. It was hundreds of agents running a screen for a day, on a budget a grad student would recognize.
  • Anthropic now owns a lab. A model company doing wet biology changes who competes with Isomorphic and Recursion.

🔍 What happened

  • Anthropic announced a life sciences research group and a wet lab in the Bay Area on September 23. The lab is rated for low-risk biology. People, not robots, do the bench work.
  • Roughly 950 Claude agents ran for 21 hours and used about 210 million tokens. They collected 200,000 reverse transcriptase sequences and narrowed them to 3,500, then to 20 for lab follow-up.
  • The standout is ART, array-associated reverse transcriptases, found in phages. The reverse transcriptase sits beside a partner gene and a row of short, evenly spaced DNA repeats.
  • Anthropic published a preprint. The team has not shown what ART does, only that the arrangement is new and structurally resembles CRISPR loci.
  • One agent's transcript includes the line noting a CRISPR-like repeat array, with the punctuation of someone surprised. Anthropic quoted it in the announcement.

💬 Smart takes

  • Feng Zhang, MIT and Broad Institute, CRISPR pioneer: the finding is "genuinely intriguing and merits further investigation." That is the most useful sentence in the whole release.
  • Anthropic, announcement: the agents did the screening and the hypothesis generation. Humans validated in the lab. The pitch is discovery at agent scale with human hands.
  • Skeptic: a repeat array is a structure, not a function. CRISPR took years from pattern to tool. This is a preprint, not a peer-reviewed mechanism.

🧭 Where this goes

  1. Likelyother labs replicate the screen on public genome data within weeks and find more ART-like systems.
  2. PossibleAnthropic partners with a biotech to characterize ART rather than doing the biochemistry alone.
  3. Wild CardART turns out to be a programmable DNA writing system, and the story becomes about who owns the patent.

🥄 The Spoon Take

The number that matters is 21 hours. A biology screen that would take a small team a semester ran overnight on rented tokens. Whether ART becomes a tool or a footnote, the cost of asking the question just collapsed. Every lab head should be asking which of their screens can be an agent job.

🤔 Pushback

Finding a pattern is cheap. Proving what it does is the expensive part, and agents have not shown they can do that yet.

·Anthropic - Claude discovers novel enzyme system·Anthropic - ART preprint PDF·The Next Web - CRISPR-like repeats found·Unite.AI - Anthropic says Claude found enzymes·Interesting Engineering - Claude enzyme discovery